Evaluation of Bromocriptine, Metoprolol and Tamsulosin in Eyes With Non-Central DME

NCT03384524 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped withdrawn during planning stages

Conditions

Diabetic Macular Edema

Interventions

DRUG: Bromocriptine 2.5 MG
DRUG: Metoprolol 25 MG
DRUG: Tamsulosin 0.4 MG
OTHER: Placebo

Sponsor

Andrew Moshfeghi, MD, MBA

Collaborators

[object Object]